Cite
HARVARD Citation
Nykiforuk, C. et al. (n.d.). O4‐04‐01: Characterization of a humanized amyloid beta oligomer monoclonal antibody (5E3) under preclinical development for passive immunotherapy of Alzheimer's disease. Alzheimer's & dementia. p. P275. [Online].